Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Curtis Cooper

Showing results (211-220 of 268) with videos related to

Pageof 27
Sort By:
Open Forum Infectious Diseases|November 16, 2018
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in Patients With Chronic Hepatitis C Virus Genotype 1 Infection Receiving Opioid Substitution Therapy: A Post Hoc Analysis of 12 Clinical TrialsJason Grebely, Massimo Puoti, Heiner Wedemeyer, et al.
Plos One|January 7, 2014
Gender differences in clinical outcomes among HIV-positive individuals on antiretroviral therapy in Canada: a multisite cohort studyAngela Cescon, Sophie Patterson, Keith Chan, et al.
Canadian Journal of Gastroenterology & Hepatology|October 15, 2014
The 3rd Canadian Symposium on Hepatitis C Virus: expanding care in the interferon-free eraSonya A MacParland, Marc Bilodeau, Jason Grebely, et al.
CMAJ Open|October 10, 2023
Trends in infection-related and infection-unrelated cancer incidence among people with and without HIV infection in Ontario, Canada, 1996-2020: a population-based matched cohort study using health administrative dataIoana A Nicolau, Rahim Moineddin, Tony Antoniou, et al.
International Journal of Epidemiology|September 30, 2009
Cohort profile: the Canadian HIV-hepatitis C co-infection cohort studyMarina B Klein, Sahar Saeed, Hong Yang, et al.
JHEP Reports : Innovation in Hepatology|April 1, 2022
Molecular epidemiology and clinical characteristics of hepatitis D virus infection in CanadaCarla Osiowy, Ken Swidinsky, Sarah Haylock-Jacobs, et al.
BMC Infectious Diseases|July 18, 2015
Life expectancy of HIV-positive individuals on combination antiretroviral therapy in CanadaSophie Patterson, Angela Cescon, Hasina Samji, et al.
Implementation Science : IS|January 17, 2016
Enhanced syphilis screening among HIV-positive men (ESSAHM): a study protocol for a clinic-randomized trial with stepped wedge designAnn N Burchell, Vanessa G Allen, Ramandip Grewal, et al.
CMAJ Open|December 9, 2014
The effects of HIV-1 subtype and ethnicity on the rate of CD4 cell count decline in patients naive to antiretroviral therapy: a Canadian-European collaborative retrospective cohort studyMarina B Klein, Jim Young, David Dunn, et al.
Antiviral Therapy|March 16, 2019
Tenofovir and emtricitabine resistance among antiretroviral-naive patients in the Canadian Observational Cohort Collaboration: implications for PrEPJaime Younger, Janet Raboud, Leah Szadkowski, et al.
Pageof 27

Showing results (211-220 of 268) with videos related to

Sort By:
Pageof 27
Open Forum Infectious Diseases|November 16, 2018
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in Patients With Chronic Hepatitis C Virus Genotype 1 Infection Receiving Opioid Substitution Therapy: A Post Hoc Analysis of 12 Clinical TrialsJason Grebely, Massimo Puoti, Heiner Wedemeyer, et al.
Plos One|January 7, 2014
Gender differences in clinical outcomes among HIV-positive individuals on antiretroviral therapy in Canada: a multisite cohort studyAngela Cescon, Sophie Patterson, Keith Chan, et al.
Canadian Journal of Gastroenterology & Hepatology|October 15, 2014
The 3rd Canadian Symposium on Hepatitis C Virus: expanding care in the interferon-free eraSonya A MacParland, Marc Bilodeau, Jason Grebely, et al.
CMAJ Open|October 10, 2023
Trends in infection-related and infection-unrelated cancer incidence among people with and without HIV infection in Ontario, Canada, 1996-2020: a population-based matched cohort study using health administrative dataIoana A Nicolau, Rahim Moineddin, Tony Antoniou, et al.
International Journal of Epidemiology|September 30, 2009
Cohort profile: the Canadian HIV-hepatitis C co-infection cohort studyMarina B Klein, Sahar Saeed, Hong Yang, et al.
JHEP Reports : Innovation in Hepatology|April 1, 2022
Molecular epidemiology and clinical characteristics of hepatitis D virus infection in CanadaCarla Osiowy, Ken Swidinsky, Sarah Haylock-Jacobs, et al.
BMC Infectious Diseases|July 18, 2015
Life expectancy of HIV-positive individuals on combination antiretroviral therapy in CanadaSophie Patterson, Angela Cescon, Hasina Samji, et al.
Implementation Science : IS|January 17, 2016
Enhanced syphilis screening among HIV-positive men (ESSAHM): a study protocol for a clinic-randomized trial with stepped wedge designAnn N Burchell, Vanessa G Allen, Ramandip Grewal, et al.
CMAJ Open|December 9, 2014
The effects of HIV-1 subtype and ethnicity on the rate of CD4 cell count decline in patients naive to antiretroviral therapy: a Canadian-European collaborative retrospective cohort studyMarina B Klein, Jim Young, David Dunn, et al.
Antiviral Therapy|March 16, 2019
Tenofovir and emtricitabine resistance among antiretroviral-naive patients in the Canadian Observational Cohort Collaboration: implications for PrEPJaime Younger, Janet Raboud, Leah Szadkowski, et al.
Pageof 27